Serum Institute writes to PMO proposing reforms in drug regulatory system

In the letter to the PMO, Prakash Kumar Singh, the Director of Government and Regulatory Affairs also sought permission to use the remaining quantities of batches of COVID and non-COVID vaccines for commercial purpose which have been used in a clinical trial

Related Keywords

Prakash Kumar Singh ,Regulatory Affairs ,Serum Institute ,Serum ,Covishield ,Covid 19 Vaccine ,Pm Modi ,பிரகாஷ் குமார் சிங் ,ஒழுங்குமுறை வாழ்க்கைத்தொழில்கள் ,சீரம் நிறுவனம் ,சீரம் ,பீயெம் மோடி ,